Ventricular tachycardia is a condition, wherein the pulse rate is more than 100 beats per minute with minimum three continuous irregular heartbeats. This condition occurs in bottom chambers of the heart and develops as an early or late complication of heart attack. Patients suffering from cardiomyopathy, myocarditis, or valvular heart disease are at a higher risk of developing ventricular tachycardia. Major reasons for ventricular tachycardia are changes in pH values, changes in blood chemistry, and lack of oxygen. If the heart rate during this condition is very high and lasts for longer time, the patient may complain of chest discomfort, fainting, palpitation, dizziness, or shortness of breath. If left untreated, it leads to ventricular fibrillation (a leading cause of cardiac death).
Request Brochure –
https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=34034
Diagnostic techniques such as continuous ambulatory electrocardiogram, intra-cardiac electrophysiology study (EPS), electrocardiogram (ECG), loop recorder, and blood tests are utilized for confirming ventricular tachycardia. Treatment of the disease depends on its symptoms and seriousness. Based on treatment, the ventricular tachycardia market has been segmented into emergency treatment and long-term treatment. The emergency segment has been sub-segmented into cardiopulmonary resuscitation (CPR), electric defibrillation (electric shock), and anti-arrhythmic medications (such as procinamide, lidocaine, amiodarone, and solatol that are injected through vein). Long-term treatment includes oral antiarrhythmic medication. However, antiarrhythmic agents are not always prescribed due to their severe side effects. Other long-term treatment options are implantation of an implantable cadioverter defibrillator (ICD), ablation procedure using a radiofrequency catheter, and cardiac resynchronization therapy. The catheter ablation procedure sub-segment is expected to expand significantly during the forecast period, owing to promising success rate of the procedure. Rising incidence of cardiac diseases such as cardiomyopathy, myocarditis, and valvular heart disease is anticipated to be the primary factor fueling the ventricular tachycardia market during the forecast period. Moreover, growing geriatric population suffering from heart diseases and changing lifestyle are other factors likely to drive the market in the near future. Furthermore, advancements in technology and improvements in existing treatment therapies are anticipated to fuel the ventricular tachycardia market during the forecast period. However, high cost of treatment is a major factor restraining the market.
Request COVID Analysis on Ventricular Tachycardia Treatment Market –
https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=34034
In terms of geography, the global ventricular tachycardia market can be classified into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. The market in North America and Europe is mature, owing to high prevalence of the disease and economic stability in these regions, which allows patients to afford expensive treatments. The market in Asia Pacific is expanding at a rapid pace, led by growing economies of China, Japan, and India. However, factors such as high cost of therapy, low awareness among patients, and lack to access to medical facilities are restraining the ventricular tachycardia market in Middle East & Africa.
Pre Book Ventricular Tachycardia Treatment Market Report –
https://www.transparencymarketresearch.com/checkout.php?rep_id=34034<ype=S
Major players operating in the global ventricular tachycardia market are CardioDx, Inc., Advanced Instrumentations Inc., Cameron Health, Inc., Bexen Cardio, CU Medical Systems, Inc., Biotronik SE & Co. KG, Pfizer Inc., Heritage Pharmaceuticals Inc., and Baxter International Inc. Some of the major institutes that are currently conducting clinical research trials on ventricular tachycardia patients are National Heart, Lung & Blood Institute, Meshalkin Research Institute of Pathology of Circulation, Institut de Recherches Internationales Servier, University of Pittsburgh (Canada), Emory University, Lawson Health Research Institute, Vanderbilt University, and Duke University.
Trending Reports of Transparency Market Research –
Dermal Fillers Market Report –
Adhesive Bandages Market –
About Us
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through ad hoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.
Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: [email protected]
